
How can spatial proteomics help uncover biomarkers of immunotherapy response and resistance? At #SITC2026, Jeremiah Wala, MD, PhD, of Dana-Farber Cancer Institute will share findings from a phase 1/2 clinical trial of copanlisib plus nivolumab in colorectal cancer.

















